Portrazza

(necitumumab)
Portrazza 800 MG in 50 ML Injection

Dosage & administration

Recommended dose of PORTRAZZA is 800 mg (absolute dose) as an intravenous infusion over 60 minutes on Days 1 and 8 of each 3-week cycle.

drug label

Portrazza prescribing information

financial assistance

Portrazza financial assistance options

Foundation programs

under insured
no insurance
goverment insurance
65+
Lilly Cares Foundation
Learn More

PubMed™ | Portrazza

Portrazza PubMed™ News

patient education

Portrazza patient education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

people also ask

Portrazza FAQs

How is the dosage of Portrazza?Portrazza is available in 1 dosages, including 16 mg/ml Injection 50 ml
What does Portrazza treat?Portrazza treats Non-Small-Cell Lung Carcinoma
What is Portrazza made of?Portrazza contains necitumumab which is a Epidermal Growth Factor Receptor Antagonist
How Is Portrazza Administered?Portrazza is administered as a Injectable
What Are The Portrazza Mechanism Of Action?Portrazza mechanism of action is HER1 Antagonists
FAQ Data Source